Skip to main content
Journal cover image

Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies

Publication ,  Conference
Muir, AJ; Jurkowski, C; Cooney, EL; Hillson, JL; Lataillade, M; Casullo, VM; Gray, T; Xu, D; Yogendran, L; Srinivasan, S
Published in: HEPATOLOGY
October 1, 2013

Duke Scholars

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2013

Volume

58

Start / End Page

744A / 745A

Location

Washington, DC

Publisher

WILEY-BLACKWELL

Conference Name

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Muir, A. J., Jurkowski, C., Cooney, E. L., Hillson, J. L., Lataillade, M., Casullo, V. M., … Srinivasan, S. (2013). Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies. In HEPATOLOGY (Vol. 58, pp. 744A-745A). Washington, DC: WILEY-BLACKWELL.
Muir, Andrew J., Claire Jurkowski, Elizabeth L. Cooney, Jan L. Hillson, Max Lataillade, Veronica Mas Casullo, Todd Gray, Dong Xu, Logesvaran Yogendran, and Subasree Srinivasan. “Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies.” In HEPATOLOGY, 58:744A-745A. WILEY-BLACKWELL, 2013.
Muir AJ, Jurkowski C, Cooney EL, Hillson JL, Lataillade M, Casullo VM, et al. Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies. In: HEPATOLOGY. WILEY-BLACKWELL; 2013. p. 744A-745A.
Muir AJ, Jurkowski C, Cooney EL, Hillson JL, Lataillade M, Casullo VM, Gray T, Xu D, Yogendran L, Srinivasan S. Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies. HEPATOLOGY. WILEY-BLACKWELL; 2013. p. 744A-745A.
Journal cover image

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2013

Volume

58

Start / End Page

744A / 745A

Location

Washington, DC

Publisher

WILEY-BLACKWELL

Conference Name

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics